文献速递产科母胎医学

美国东北部门诊产科提供者遗传咨询实践调查

Genetic counseling practices among outpatient obstetric providers in the Northeast.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-09-06

一项多中心匿名调查研究于2021年10月至2022年3月调查了7个站点635名门诊产前保健提供者,回收419份问卷(应答率66%)。98%提供者提供筛查性遗传检测,但仅37%对所有患者提供诊断性检测,住院医师、服务少数族裔及公共保险人群的提供者较少普遍提供诊断性检测。

要点

  • 98%提供者提供筛查性遗传检测,但仅37%对所有患者提供诊断性检测。
  • 住院医师较主治医师更少提供诊断性检测(多变量OR 0.33,95%CI 0.17-0.62)。
  • 服务主要私险人群的提供者更可能提供诊断性检测(多变量OR 2.84,95%CI 1.20-6.74)。

核心结论

  • 尽管推荐对所有患者提供遗传筛查和诊断性检测,但没有任何提供者群体普遍提供诊断性检测。
  • 服务种族和族裔少数群体、公共保险人群及主要语言非英语人群的提供者较少报告普遍提供诊断性遗传检测。

研究设计与样本

  • 多中心匿名调查研究,于2021年10月至2022年3月进行。
  • 向7个站点的635名门诊产前保健提供者发送问卷,包括家庭医学和产科主治医师、住院医师、母胎医学研究员、执业护士、医师助理和助产士。
  • 共419名提供者回复,总应答率为66%。
  • 主要结局为对「您是否对所有患者提供诊断性遗传检测?」回答「是,所有患者」的受访者比例。
  • 诊断性检测定义为绒毛膜绒毛取样或羊膜腔穿刺;筛查性遗传检测定义为序贯筛查、四联筛查、游离DNA筛查或「其他」。

主要发现

  • 98%的提供者提供筛查性遗传检测。
  • 37%的提供者对所有患者提供诊断性检测,18%完全不提供,44%仅在存在特定患者因素时提供。
  • 54.8%的主治医师报告普遍提供诊断性检测。
  • 单变量分析中,住院医师较主治医师更少提供诊断性检测(OR 0.18,95%CI 0.11-0.30)。
  • 单变量分析中,服务非西班牙裔白人患者的提供者更可能提供诊断性检测(OR 2.26,95%CI 1.51-3.39);服务主要私险人群的提供者较公共保险人群更可能提供诊断性检测(OR 6.25,95%CI 3.60-10.85);服务主要英语人群的提供者更可能提供诊断性遗传检测(OR 0.43,95%CI 0.26-0.69)。

关键数值与推荐

  • 多变量分析中,与提供诊断性检测显著相关的因素包括培训水平(住院医师OR 0.33,95%CI 0.17-0.62;P=.0006;高级实践提供者OR 0.34,95%CI 0.15-0.82;P=.02)。
  • 多变量分析中,至少三分之一患者认同为「其他西班牙裔」与提供诊断性检测相关(OR 0.42,95%CI 0.23-0.77;P=.005)。
  • 多变量分析中,主要私险而非公共保险与提供诊断性检测相关(OR 2.84,95%CI 1.20-6.74;P=.02)。

临床怎么用

  • 美国妇产科医师学会推荐所有孕妇无论风险因素均应获得遗传筛查和诊断性检测。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American College of Obstetricians and Gynecologists recommends all pregnant people be offered genetic screening and diagnostic testing regardless of risk factors. Previous studies have demonstrated disparities in referrals for genetic testing by race outside of pregnancy, but limited data exist regarding genetic counseling practices during pregnancy. OBJECTIVE: This study aimed to describe how patient, provider, and practice demographics influence the offering of diagnostic prenatal genetic testing by outpatient prenatal care providers. STUDY DESIGN: This was a multicenter anonymous survey study conducted between October 2021 and March 2022. Outpatient prenatal care providers, including family medicine and obstetrics attendings, residents, maternal-fetal medicine fellows, nurse practitioners, physician assistants, and midwives, were surveyed about their genetic counseling practices and practice demographics. The primary outcome was the proportion of respondents who answered "yes, all patients" to the survey question "Do you offer diagnostic genetic testing to all patients?" The secondary outcomes included the association between patient and practice demographics and offering diagnostic testing. Diagnostic testing was defined as chorionic villus sampling or amniocentesis. Screening genetic tests were defined as sequential screen, quadruple screen, cell-free DNA screening, or "other." The chi-square test or Fisher exact test was used as appropriate. For the outcome answers of diagnostic testing, logistic regression was performed to assess the association between the answer of diagnostic genetic testing and the current training level of providers, race and ethnicity, and insurance status variables. Multivariable analysis was performed to adjust for confounders. RESULTS: A total of 635 outpatient prenatal care providers across 7 sites were sent the survey. Overall, 419 providers responded for a total response rate of 66%. Of the providers who responded, most were attendings (44.9%), followed by residents (37.5%). Providers indicated the race, insurance status, and primary language of their patient population. Screening genetic testing was offered by 98% of providers. Per provider report, 37% offered diagnostic testing to all patients, 18% did not offer it at all, and 44% only offered it if certain patient factors were present. Moreover, 54.8% of attendings reported universally offering diagnostic testing. On univariable analysis, residents were less likely to offer diagnostic testing than attendings (odds ratio, 0.18; 95% confidence interval, 0.11-0.30). Providers who serve non-Hispanic Black, Hispanic Black, and other Hispanic patients were less likely to report offering diagnostic testing than other patient populations. Providers who served non-Hispanic Whites were more likely to offer diagnostic testing (odds ratio, 2.26; 95% confidence interval, 1.51-3.39). Patient populations who were primarily privately insured were more likely to be offered diagnostic testing compared with primarily publicly insured patients (odds ratio, 6.25; 95% confidence interval, 3.60-10.85). Providers who served a primarily English-speaking population were more likely to offer diagnostic genetic testing than other patient populations (odds ratio, 0.43; 95% confidence interval, 0.26-0.69). On multivariable analysis, the factors that remained significantly associated with offering diagnostic testing included level of training (resident odds ratio, 0.33; 95% confidence interval, 0.17-0.62; P=.0006; advanced practice provider odds ratio, 0.34; 95% confidence interval, 0.15-0.82; P=.02), having at least one-third of the patient population identify as "other Hispanic" (odds ratio, 0.42; 95% confidence interval, 0.23-0.77; P=.005), and having private insurance instead of public insurance (primarily private insured odds ratio, 2.84; 95% confidence interval, 1.20-6.74; P=.02). CONCLUSION: Although offering genetic screening and diagnostic testing to all patients is recommended, no provider group universally offers diagnostic testing. Providers who serve populations from a racial and ethnic minority, those with public insurance, and those whose primary language is not English are less likely to report universally offering diagnostic genetic testing.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Peterson JA, Szeto L, Wodoslawsky S, et al. Genetic counseling practices among outpatient obstetric providers in the Northeast. Am J Obstet Gynecol MFM. 2023. PMID: 37683764. doi:10.1016/j.ajogmf.2023.101150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。